Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
Insider Transaction Report
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for an average price of $12.2478 per share, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Daniel Dines, CEO and Chairman of UiPath, Inc., reported a sale of Class A Common Stock.
- The transaction involved 45,000 shares of Class A Common Stock.
- The sale occurred on July 25, 2025.
- The average sale price was $12.2478 per share, with prices ranging from $12.1800 to $12.3200.
- The sale was conducted in compliance with a qualified selling plan adopted pursuant to Rule 10b5-1.
- Following the transaction, Dines beneficially owns 4,743,376 shares indirectly through Ice Vulcan Holding Limited, 24,918,585 shares directly, and 240,000 shares indirectly by his spouse.
Sentiment
Score: 4
Explanation: The sale of shares by the CEO, while executed under a pre-arranged 10b5-1 plan, represents a reduction in insider ownership. While the plan mitigates concerns about opportunistic selling, any insider sale can be perceived as a neutral to slightly negative signal regarding management's immediate outlook on the stock's valuation.
Positives
- The sale was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to immediate market conditions.
Negatives
- CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may interpret the sale as a signal regarding insider confidence, though the pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling.
Key Dates
| Date | Description |
|---|---|
| 07/25/2025 | Date of earliest transaction for the sale of Class A Common Stock by Daniel Dines. |
Recommendation
holdThe filing details a pre-planned sale by the CEO under a 10b5-1 plan, which is a routine event for many executives for diversification or liquidity. While it's an insider sale, the pre-arranged nature reduces the immediate negative signal often associated with ad-hoc sales. The transaction itself does not provide new fundamental information about the company's performance or future prospects, thus a 'hold' recommendation is appropriate as it doesn't warrant a change in investment thesis based solely on this filing.
Keywords
UiPath, PATH, Daniel Dines, insider trading, Form 4, stock sale, 10b5-1 plan, CEO, Chairman, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.